<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

<title>HIGH DOSE TK - QUICK SUMMARY</title>

<script type="text/javascript">
window.onload = function() {
  var imgs = document.getElementsByTagName('img'), i, img;
  for (i = 0; i < imgs.length; i++) {
    img = imgs[i];
    // center an image if it is the only element of its parent
    if (img.parentElement.childElementCount === 1)
      img.parentElement.style.textAlign = 'center';
  }
};
</script>





<style type="text/css">
body, td {
   font-family: sans-serif;
   background-color: white;
   font-size: 13px;
}

body {
  max-width: 800px;
  margin: auto;
  padding: 1em;
  line-height: 20px;
}

tt, code, pre {
   font-family: Consolas, 'Lucida Console', Monaco, monospace;
}

h1 {
   font-size:2.2em;
}

h2 {
   font-size:1.8em;
}

h3 {
   font-size:1.4em;
}

h4 {
   font-size:1.0em;
}

h5 {
   font-size:0.9em;
}

h6 {
   font-size:0.8em;
}

a:visited {
   color: rgb(50%, 0%, 50%);
}

pre, img {
  max-width: 100%;
}
pre {
  overflow-x: auto;
}
pre code {
   display: block; padding: 0.5em;
}

code {
  font-size: 92%;
  border: 1px solid #ccc;
}

code[class] {
  background-color: #F8F8F8;
}

table {
   max-width: 95%;
   border: 1px solid #ccc;
}
 
th {
  background-color: #000000;
  color: #ffffff;
}
 
td {
  background-color: #dcdcdc;
}

blockquote {
   color:#666666;
   margin:0;
   padding-left: 1em;
   border-left: 0.5em #EEE solid;
}

hr {
   height: 0px;
   border-bottom: none;
   border-top-width: thin;
   border-top-style: dotted;
   border-top-color: #999999;
}

@media print {
   * {
      background: transparent !important;
      color: black !important;
      filter:none !important;
      -ms-filter: none !important;
   }

   body {
      font-size:12pt;
      max-width:100%;
   }

   a, a:visited {
      text-decoration: underline;
   }

   hr {
      visibility: hidden;
      page-break-before: always;
   }

   pre, blockquote {
      padding-right: 1em;
      page-break-inside: avoid;
   }

   tr, img {
      page-break-inside: avoid;
   }

   img {
      max-width: 100% !important;
   }

   @page :left {
      margin:
   }

   @page :right {
      margin: 
   }

   p, h2, h3 {
      orphans: 3; widows: 3;
   }

   h2, h3 {
      page-break-after: avoid;
   }
}
</style>



</head>

<body>
<h1>HIGH DOSE TK - QUICK SUMMARY</h1>

<h2>STUDY INFORMATION</h2>

<pre><code>Study No.                       | RRDCC-PK-14-068                             
Project                         | HBV Capsid (2)                              
Theme No.                       | 7907                                        
Compound SRN                    | RO7049389-000                               
Compound ERN                    | RO7049389-000-005                           
GLP Status                      | Non-GLP                                     
Safety Plan ID                  | N/A                                         
Groups                          | 5                                           
Doses                           | 0, 100, 300, and 900 mpk                    
Route of Administration         | Oral Gavage                                 
Frequency of administration     | qd                                          
Animal Species and Strain       | Wistar-Han Rat                              
First Dosing Date               | -                                           
Last Dosing Date                | -                                           
Necropsy Date                   | -                                           
Day                             | 2                                           
Study Director                  | Xiaoqin Wu                                  
TPL                             | Spacey Sun                                  
DPL                             | Dr. Frances Wang                            
In-life Procedures              | Xiaoqin Wu, Sunfeng Huang                   
Formulation Analysis            | Sheng Zhong, Jian Xin, Yan Bo, Dr. Wenzhe Lu
Bioanalysis                     | Sheng Zhong, Jian Xin, Yan Bo, Dr. Wenzhe Lu
Clinical Pathology              | Guoji Zhang (Medicilon)                     
Histopathology                  | -                                           
Histopathology Peer Review      | -                                           
 -- Group Information --        |  -- Group Information --                    
Group 1: 101-103                | enter information here                      
Group 2: 201-203                | enter information here                      
Group 3: 301-303                | enter information here                      
</code></pre>

<hr/>

<h2>1. BODY WEIGHT</h2>

<h3>1.1 Body Weight - Summary Table</h3>

<pre><code>      DOSE    DAY_1    DAY_2
   0 mg/kg 230 ± 10 231 ± 11
  50 mg/kg  224 ± 2  147 ± 7
 300 mg/kg  233 ± 7  227 ± 3
 900 mg/kg  229 ± 5  222 ± 7
</code></pre>

<h3>1.2 Body Weight - Statistical Analysis</h3>

<pre><code>                DOSE  DAY_1   DAY_2
             0 mg/kg    ---     ---
            50 mg/kg    --- p&lt;0.001
           300 mg/kg    ---     ---
           900 mg/kg    ---     ---
              LEVENE   PASS    PASS
          ANOVA (p=) 0.4445       0
 KRUSKAL-WALLIS (p=)      -       -
         - SUMMARY -    ---     ***
</code></pre>

<h3>1.3 Body Weight - Charts</h3>

<p><img src="data:image/png;base64,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" alt="plot of chunk unnamed-chunk-5"/> </p>

<p><img src="data:image/png;base64,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" alt="plot of chunk unnamed-chunk-6"/> </p>

<hr/>

<h2>2 BODY WEIGHT GAIN</h2>

<h3>2.1 Body Weight Gain - Summary Table</h3>

<pre><code>      DOSE   DAY_2     SUM
   0 mg/kg   1 ± 3   1 ± 3
  50 mg/kg -77 ± 5 -77 ± 5
 300 mg/kg  -6 ± 4  -6 ± 4
 900 mg/kg  -7 ± 6  -7 ± 6
</code></pre>

<h3>2.2 Body Weight Gain - Statistical Aanalysis</h3>

<pre><code>                DOSE   DAY_2     SUM
             0 mg/kg     ---     ---
            50 mg/kg p&lt;0.001 p&lt;0.001
           300 mg/kg     ---     ---
           900 mg/kg     ---     ---
              LEVENE    PASS    PASS
          ANOVA (p=)       0       0
 KRUSKAL-WALLIS (p=)       -       -
         - SUMMARY -     ***     ***
</code></pre>

<h3>2.3 Body Weight Gain - Charts</h3>

<p><img src="data:image/png;base64,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" alt="plot of chunk unnamed-chunk-9"/> </p>

<p><img src="data:image/png;base64,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" alt="plot of chunk unnamed-chunk-10"/> </p>

<p><img src="data:image/png;base64,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" alt="plot of chunk unnamed-chunk-11"/> </p>

<hr/>

<h2>3. CLINICAL PATHOLOGY</h2>

<h3>3.1 Clinical Pathology - Summary Table</h3>

<pre><code>      DOSE           ALP        TBIL        UREA            ASP
   0 mg/kg   171 ± 33.29     0.1 ± 0 4.76 ± 0.55    115 ± 12.49
  50 mg/kg   311 ± 10.15 0.13 ± 0.06 4.64 ± 0.36  101.33 ± 1.53
 300 mg/kg 172.67 ± 9.02     0.1 ± 0 4.64 ± 0.36         95 ± 9
 900 mg/kg   175 ± 22.72 0.13 ± 0.06 5.12 ± 0.55 105.33 ± 14.98

---

      DOSE          ALT   GGT           UN        CREA
   0 mg/kg 23.33 ± 4.04 0 ± 0 13.33 ± 1.53 0.17 ± 0.06
  50 mg/kg 31.33 ± 2.08 0 ± 0       13 ± 1   0.2 ± 0.1
 300 mg/kg    29 ± 2.65 0 ± 0       13 ± 1     0.1 ± 0
 900 mg/kg   53 ± 18.03 0 ± 0 14.33 ± 1.53     0.2 ± 0

---

      DOSE          TP         ALB         GLO          AG
   0 mg/kg 6.27 ± 0.15   4.5 ± 0.1 1.77 ± 0.12 2.55 ± 0.17
  50 mg/kg  6.2 ± 0.17   4.4 ± 0.1   1.8 ± 0.1 2.45 ± 0.12
 300 mg/kg 5.93 ± 0.15 4.37 ± 0.31 1.57 ± 0.15 2.82 ± 0.49
 900 mg/kg     5.8 ± 0  4.3 ± 0.17  1.5 ± 0.17  2.9 ± 0.48

---

      DOSE           GLU          TCHO            TG           NA.
   0 mg/kg  85.67 ± 6.11     89 ± 5.29    81 ± 40.95 142.67 ± 0.58
  50 mg/kg  89.67 ± 3.21 89.33 ± 23.59  56.67 ± 12.5       143 ± 2
 300 mg/kg 84.33 ± 18.23 76.67 ± 12.66    55 ± 18.36    143 ± 2.65
 900 mg/kg    87 ± 16.09 62.67 ± 14.57 70.67 ± 30.66 143.67 ± 0.58

---

      DOSE           K            CL           CA           P
   0 mg/kg 5.93 ± 0.71        99 ± 1 10.73 ± 0.06  7.3 ± 0.69
  50 mg/kg  6.4 ± 0.56    100 ± 1.73 11.07 ± 0.15 8.57 ± 0.55
 300 mg/kg 6.03 ± 0.25 100.33 ± 1.53 10.57 ± 0.15 9.27 ± 0.87
 900 mg/kg 6.13 ± 0.15 100.33 ± 1.15 10.87 ± 0.64  9.6 ± 1.51

---

      DOSE              CK         WBC         RBC          HGB
   0 mg/kg    854 ± 297.61 5.63 ± 1.61 6.96 ± 0.54  14.3 ± 0.14
  50 mg/kg 1090.67 ± 273.5 4.33 ± 1.94 6.86 ± 0.52  8.1 ± 10.04
 300 mg/kg 587.33 ± 200.28 5.29 ± 1.42 6.99 ± 0.52 13.83 ± 0.65
 900 mg/kg 799.67 ± 341.52 6.11 ± 0.99 7.68 ± 0.07 15.07 ± 0.15

---

      DOSE          HCT          MCV           MCH          MCHC
   0 mg/kg 42.65 ± 2.62 61.35 ± 0.92  20.55 ± 1.34    33.5 ± 1.7
  50 mg/kg 42.95 ± 3.46  62.6 ± 0.28 11.35 ± 13.79 18.05 ± 21.99
 300 mg/kg  41.23 ± 2.4 59.07 ± 1.75   19.8 ± 0.72  33.47 ± 0.35
 900 mg/kg    45 ± 0.89 58.67 ± 1.27  19.63 ± 0.38  33.47 ± 0.47

---

      DOSE             PLT       RDW.CV        NEUT      NEUT_PER
   0 mg/kg  1051.5 ± 64.35  13.4 ± 1.41 1.19 ± 0.93 19.55 ± 10.82
  50 mg/kg    805 ± 205.06 12.15 ± 0.49 0.48 ± 0.32   10.7 ± 2.55
 300 mg/kg 1071.33 ± 49.22    12 ± 0.78 0.66 ± 0.24  12.47 ± 1.98
 900 mg/kg 1049.33 ± 58.79 11.13 ± 0.91 0.68 ± 0.07  11.37 ± 2.66

---

      DOSE       LYMPH    LYMPH_PER        MONO    MONO_PER
   0 mg/kg  4.2 ± 0.57  76.2 ± 11.6 0.07 ± 0.03 1.25 ± 0.21
  50 mg/kg  3.7 ± 1.59 86.25 ± 2.05 0.06 ± 0.01 1.45 ± 0.49
 300 mg/kg 4.45 ± 1.17 84.37 ± 1.96 0.06 ± 0.02 1.07 ± 0.06
 900 mg/kg 5.23 ± 1.02 85.33 ± 3.15 0.06 ± 0.01    1 ± 0.26

---

      DOSE          EO      EO_PER        BASO    BASO_PER
   0 mg/kg  0.1 ± 0.06 1.75 ± 0.49    0.01 ± 0 0.23 ± 0.12
  50 mg/kg 0.04 ± 0.01     0.9 ± 0    0.01 ± 0     0.1 ± 0
 300 mg/kg 0.06 ± 0.02 1.23 ± 0.38 0.01 ± 0.01   0.1 ± 0.1
 900 mg/kg 0.07 ± 0.01 1.17 ± 0.35    0.01 ± 0 0.15 ± 0.07

---

      DOSE         LUC     LUC_PER            RET     RET_PER
   0 mg/kg 0.05 ± 0.04  0.93 ± 0.4    416 ± 37.25 6.12 ± 0.55
  50 mg/kg 0.05 ± 0.03 0.85 ± 0.35 334.75 ± 85.35 4.65 ± 1.16
 300 mg/kg 0.04 ± 0.02   0.7 ± 0.2 283.67 ± 39.88  4.02 ± 0.9
 900 mg/kg 0.06 ± 0.02 0.95 ± 0.35  272.7 ± 30.55 3.54 ± 0.35

---
</code></pre>

<h3>3.2 Clinical Pathology - Statistical Analysis</h3>

<pre><code>                DOSE     ALP    ALT     TP RET_PER
             0 mg/kg     ---    ---    ---     ---
            50 mg/kg p&lt;0.001    ---    ---     ---
           300 mg/kg     ---    ---    ---     ---
           900 mg/kg     --- p&lt;0.01 p&lt;0.05  p&lt;0.05
              LEVENE    PASS      ~   PASS    PASS
          ANOVA (p=)   1e-04 0.0112   0.01  0.0374
 KRUSKAL-WALLIS (p=)       -      -      -       -
         - SUMMARY -     ***      *      *       *
</code></pre>

<h4>Full Names of Indices with Statistical Significance</h4>

<pre><code>ALP  -  Alkaline Phosphatase (U/L)    
ALT  -  Alanine Aminotransferase (U/L)
TP  -  Total Protein (g/dL)           
RET_PER  -  Reticulocyte (%)          
</code></pre>

<h3>3.3 Clinical Pathology - Charts</h3>

<p><img src="data:image/png;base64,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" alt="plot of chunk unnamed-chunk-15"/> </p>

<hr/>

<h2>4. ADDITIONAL INFORMATION</h2>

<pre><code>NO EVENTS TO REPORT
</code></pre>

<pre><code>THE SUMMARY WAS CREATED ON 2015-03-16 18:46:31.
</code></pre>

</body>

</html>
